Cannabics Pharmaceuticals Stock Price on December 3, 2024
| CNBX Stock | USD 0.01 0.0007 7.00% |
If you're considering investing in Cannabics Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Cannabics Pharmaceuticals stands at 0.01, as last reported on the 4th of December, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. Cannabics Pharmaceuticals appears to be out of control, given 3 months investment horizon. Cannabics Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0398, which signifies that the company had a 0.0398% return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Cannabics Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Cannabics Pharmaceuticals' Standard Deviation of 9.38, mean deviation of 2.84, and Risk Adjusted Performance of 0.0391 to double-check if our risk estimates are consistent with your expectations.
Cannabics Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Cannabics |
Sharpe Ratio = 0.0398
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CNBX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.52 actual daily | 84 84% of assets are less volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Cannabics Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cannabics Pharmaceuticals by adding it to a well-diversified portfolio.
Related Headline
Pmv Pharmaceuticals Headline on 3rd of December 2024
Discover 3 US Penny Stocks With Market Caps Over 40M by simplywall.st
As the U.S. stock market reaches new heights with record closings for the SP 500 and Nasdaq, investors are exploring diverse opportunities beyond large-cap tech stocks. Penny stocks, while often associated with smaller or newer companies, remain a relevant area for those seeking unique investment possibilities. Despite their vintage-sounding name, these stocks can offer surprising value when backed by strong financials, providing potential for significant returns and stability.
Cannabics Pharmaceuticals Valuation on December 3, 2024
It is possible to determine the worth of Cannabics Pharmaceuticals on a given historical date. On December 3, 2024 Cannabics was worth 0.01 at the beginning of the trading date compared to the closed value of 0.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cannabics Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Cannabics Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cannabics Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cannabics Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.01 | 0.01 | 0.01 | 0.01 | 47,900 | |
12/03/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 3,100 |
| 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Backtest Cannabics Pharmaceuticals | | | Cannabics Pharmaceuticals History | | | Cannabics Pharmaceuticals Valuation | Previous | Next |
Cannabics Pharmaceuticals Trading Date Momentum on December 3, 2024
| On December 04 2024 Cannabics Pharmaceuticals was traded for 0.01 at the closing time. The top price for the day was 0.01 and the lowest listed price was 0.01 . There was no trading activity during the period 0.0. Lack of trading volume on December 4, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 7.00% . The overall trading delta against the current closing price is 7.00% . |
Cannabics Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Cannabics Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cannabics Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cannabics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cannabics Pharmaceuticals Pink Sheet history
Cannabics Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cannabics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cannabics Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cannabics Pharmaceuticals stock prices may prove useful in developing a viable investing in Cannabics Pharmaceuticals
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. Cnbx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Cannabics Pharmaceuticals Pink Sheet Technical Analysis
Cannabics Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Cannabics Pharmaceuticals Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Cannabics Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cannabics Pharmaceuticals December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Cannabics Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cannabics Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cannabics Pharmaceuticals pink sheet market strength indicators, traders can identify Cannabics Pharmaceuticals entry and exit signals to maximize returns
Cannabics Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cannabics Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cannabics Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cannabics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0391 | |||
| Jensen Alpha | 0.5415 | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (0.20) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.